Cancer Prevention, Genetics and Risk Assessment

Understanding genetic predisposition and modifiable risk factors is fundamental to reducing the global burden of breast cancer. This track explores hereditary breast cancer syndromes, BRCA1/BRCA2 mutations, multigene panel testing, genetic counseling, polygenic risk assessment, lifestyle interventions, and preventive strategies. Participants will discuss advances in cancer screening, chemoprevention, risk prediction models, environmental influences, and population health initiatives. The session also highlights precision prevention approaches that integrate genomic information with personalized risk management to improve early detection and reduce breast cancer incidence.

 

    Related Conference of Cancer Prevention, Genetics and Risk Assessment

    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Cancer Prevention, Genetics and Risk Assessment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in